The global pharmaceutical and clinical research landscape is undergoing a paradigm shift toward Decentralized Clinical Trials (DCTs). As a leading Wearable Clinical Data Collection Devices Manufacturer, we address the critical need for continuous, high-fidelity patient monitoring. Traditional site-based trials often suffer from "snapshot" data—sporadic measurements that fail to capture the nuances of a patient's daily life. Our wearable solutions provide a continuous stream of biometric data, enabling "Digital Biomarkers" that offer deeper insights into drug efficacy and safety.
By integrating multi-modal sensors—including ECG, SpO2, actigraphy, and temperature—our devices reduce patient burden, increase diversity in recruitment, and significantly lower the drop-out rates that plague modern drug development cycles.
Leveraging 4G/5G and Bluetooth Low Energy (BLE) to ensure data is synchronized instantly with cloud-based EDC systems, maintaining the chain of custody for clinical evidence.
Our manufacturing processes adhere to ISO 13485 standards, ensuring all wearable devices meet stringent FDA 21 CFR Part 11 and GDPR data privacy requirements.
Lightweight, ergonomic, and non-invasive form factors designed for long-term wearability, ensuring high compliance among elderly and pediatric populations.
The market for Clinical Data Collection Devices is projected to grow at a CAGR of 18.5% through 2030. Currently, North America and Europe lead in adoption, but the Asia-Pacific region is the fastest-growing hub for manufacturing and trial execution.
Localization Support: We understand that clinical trials are global but compliance is local. Our devices support multi-language interfaces and are pre-configured with regional connectivity modules (Cat-M1, NB-IoT, Global LTE) to ensure seamless operation in over 120 countries. We provide localized technical support and regulatory documentation for NMPA (China), EMA (Europe), and FDA (USA) submissions.
As a technology-driven supplier, our R&D pipeline focuses on three pillars of Information Gain:
Moving beyond simple data logging to on-device anomaly detection. Our next-gen devices will use TinyML to identify cardiac arrhythmias or respiratory distress in real-time, alerting investigators immediately.
Development of flexible, skin-conformable "electronic tattoos" that offer medical-grade precision without the bulk of traditional wearables.
Implementing blockchain-based data anchoring to ensure that every data point collected is immutable and verifiable, crucial for regulatory audits.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
Medical-grade devices must demonstrate high accuracy, repeatability, and reliability. They require certifications like CE (MDR) or FDA 510(k), and their data processing must comply with HIPAA/GDPR. Unlike consumer wearables, they provide raw data access for independent verification.
We utilize end-to-end encryption (AES-256), secure boot protocols, and unique device identification. Data is never stored locally in an unencrypted state, and transmission occurs via secure VPN tunnels or HTTPS/TLS protocols.
Yes, our systems are built with open API architectures (RESTful APIs) and support HL7/FHIR standards, allowing seamless integration with major Electronic Data Capture (EDC) platforms like Medidata or Veeva.
Absolutely. With an 11,000 sqm facility and over 230 employees, we have the vertical integration to handle industrial design, PCBA development, firmware coding, and mass production for bespoke clinical research tools.
Trial Medical
